(Q31415756)

2 July 2017

title

Sildenafil produces antinociception and increases morphine antinociception in the formalin test (English)

1 reference

2 July 2017

1 reference

Mixcoatl-Zecuatl T

1

1 reference

2 July 2017

Aguirre-Bañuelos P

series ordinal

2

1 reference

2 July 2017

Granados-Soto V

series ordinal

3

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

European Journal of Pharmacology

2 July 2017

published in

1 reference

2 July 2017

volume

400

1 reference

2 July 2017

issue

1

1 reference

2 July 2017

page(s)

81-87

1 reference

Peripheral and central antinociceptive actions of ethylketocyclazocine in the formalin test

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Nitric oxide signaling in pain and nociceptor sensitization in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Sildenafil, a novel effective oral therapy for male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

II - Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalins and opioid antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Peripheral opioid modulation of pain and inflammation in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Ethical guidelines for investigations of experimental pain in conscious animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Effect of topical administration of l‐arginine on formalin‐induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Involvement of the mu-opiate receptor in peripheral analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Multiple opioid systems and pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Further evidence that nitric oxide modifies acute and chronic morphine actions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

7 January 2021

cGMP signal termination

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Characterization of prostanoid receptor-evoked responses in rat sensory neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Local analgesic effect of endogenous opioid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900361-7

10.1016/S0014-2999(00)00361-7

7 January 2021

Identifiers

DOI

1 reference

2 July 2017

1 reference